Nordic strategy drives high revenue and earnings growth - revenue guidance narrowed upwardsMatas Group's strategy ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in ...

Noble Corporation plc ("Noble", the "Company") (NYSE: NE, CSE: NOBLE) announces that today, Noble has submitted a request for the ...

November 14, 2024Announcement no. 22 BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 Revenue growth and strategic execution COPENHAGEN, Denm ...

Denmark is a founding member of the European Space Agency and on Wednesday formally committed to safe and responsible space ...

Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back program in Danske Bank ...

No. 11 / 2024 Zealand Pharma to participate in the Jefferies London Healthcare Conference Copenhagen, Denmark – Zealand ...

As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with Nas ...

As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with ...

Alexander Lacik, Chief Executive Officer of Pandora A/S, has reported the sale of 10,000 shares at a total consideration of DKK 10,762,768, and now holds a total of 247,205 shares in the company.